Suppr超能文献

细胞色素P450c17的R347H和R358Q突变通过破坏与细胞色素P450氧化还原酶和细胞色素b5的相互作用,选择性地破坏17,20-裂解酶活性。

P450c17 mutations R347H and R358Q selectively disrupt 17,20-lyase activity by disrupting interactions with P450 oxidoreductase and cytochrome b5.

作者信息

Geller D H, Auchus R J, Miller W L

机构信息

Department of Pediatrics, University of California, San Francisco 94143-0978, USA.

出版信息

Mol Endocrinol. 1999 Jan;13(1):167-75. doi: 10.1210/mend.13.1.0219.

Abstract

Cytochrome P450c17 catalyzes steroid 17alpha-hydroxylase and 17,20-lyase activities and hence is a key enzyme in the production of human glucocorticoids and sex steroids. These two activities are catalyzed in a single substrate-binding site but are regulated independently in human physiology. We have recently shown that cytochrome b5 facilitates 17,20-lyase activity by allosterically promoting the interaction of P450c17 with P450 oxidoreductase (OR) and that the human P450c17 mutations, R347H and R358Q, selectively destroy 17,20-lyase activity while sparing 17alpha-hydroxylase activity. We transfected COS-1 cells with vectors for these P450c17 mutants and found that an excess of OR and b5 restored a small amount of 17,20-lyase activity, suggesting the mutations interfere with electron donation. To determine whether these mutations selectively interfere with the interaction of P450c17 and its electron-donating system, we expressed each P450cl7 mutant in yeast with or without OR, b5, or both, and measured enzyme kinetics in yeast microsomes using pregnenolone and 17alpha-hydroxypregnenolone as substrates. The apparent Michaelis-Menten (Km) values for the R347H mutant with and without coexpressed OR were 0.2 and 0.6 microM, respectively, and for the R358Q mutant with and without OR they were 0.3 and 0.4 microM, respectively; these values did not differ significantly from the wild-type values of 0.4 and 0.8 microM with and without OR, respectively. Furthermore, coincubation with 17alpha-hydroxypregnenolone showed a competitive mechanism for interference of catalysis. The similar kinetics and the competitive inhibition prove that the mutations did not affect the active site. Coexpression of the mutants with OR yielded insignificant 17,20-lyase activity, but addition of a 30:1 molar excess cytochrome b5 to these microsomes restored partial 17,20-lyase activity, with the R358Q mutant achieving twice the activity of the R347H mutant. These data indicate that both mutations selectively interfere with 17,20-lyase activity by altering the interaction of P450c17 with OR, thus proving that the lyase activity was disrupted by interfering with electron transfer. Furthermore, the data offer the first evidence that R347 is a crucial component of the site at which b5 interacts with the P450c17 x OR complex to promote electron transfer.

摘要

细胞色素P450c17催化类固醇17α-羟化酶和17,20-裂解酶活性,因此是人类糖皮质激素和性类固醇生成中的关键酶。这两种活性在单个底物结合位点催化,但在人体生理学中受到独立调节。我们最近发现,细胞色素b5通过变构促进P450c17与P450氧化还原酶(OR)的相互作用来促进17,20-裂解酶活性,并且人类P450c17突变R347H和R358Q选择性地破坏17,20-裂解酶活性,同时保留17α-羟化酶活性。我们用这些P450c17突变体的载体转染COS-1细胞,发现过量的OR和b5恢复了少量的17,20-裂解酶活性,这表明这些突变干扰了电子供体。为了确定这些突变是否选择性地干扰P450c17与其电子供体系统的相互作用,我们在有或没有OR、b5或两者的情况下在酵母中表达每个P450c17突变体,并使用孕烯醇酮和17α-羟孕烯醇酮作为底物测量酵母微粒体中的酶动力学。有和没有共表达OR的R347H突变体的表观米氏(Km)值分别为0.2和0.6微摩尔,有和没有OR的R358Q突变体的表观米氏值分别为0.3和0.4微摩尔;这些值与有和没有OR时野生型的0.4和0.8微摩尔值没有显著差异。此外,与17α-羟孕烯醇酮共同孵育显示出催化干扰的竞争机制。相似的动力学和竞争性抑制证明这些突变没有影响活性位点。突变体与OR共表达产生的17,20-裂解酶活性不显著,但向这些微粒体中添加30:1摩尔过量的细胞色素b5恢复了部分17,20-裂解酶活性,R358Q突变体的活性是R347H突变体的两倍。这些数据表明,这两种突变都通过改变P450c17与OR的相互作用选择性地干扰17,20-裂解酶活性,从而证明裂解酶活性是通过干扰电子传递而被破坏的。此外,这些数据提供了第一个证据,即R347是b5与P450c17 x OR复合物相互作用以促进电子传递的位点的关键组成部分。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验